Company / Gross Profit per Share
Phathom Pharmaceuticals, Inc. Gross Profit per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$2.23
FY2025
5-year range
$0.00 / $2.23
FY2022-FY2025
Trend
+24954.8%
vs FY2024
Sector context
#21 of 29
Health Care
What the data says
Gross Profit per Share changed +24955% YoY in FY2025, a notable deviation from the 2-year average annual change of +12463%.
Based on SEC 10-K filings.
2.23 in FY2025.
Improved from $0.01 to $2.23 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#21 of 29 in Health CareTop 72% of 29This company $2.23 Sector average $8.11
▼
-72.5% below sector average
Key checks
Key Insights
- In FY2025, gross profit per share increased 24954.8% year-over-year.
- Ranks #21 out of 29 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -6.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.23 | +24954.8% |
| FY2024 | $0.01 | -28.5% |
| FY2023 | $0.01 | - |
| FY2022 | $0.00 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026